Shares of Viatris Inc. VTRS advanced 1.72% to $11.25 Friday, on what proved to be an all-around rough trading session for the ...
Shares of Viatris Inc. VTRS advanced 1.19% to $11.06 Thursday, on what proved to be an all-around dismal trading session for ...
Como parte de su compromiso con la mejora de la atención sanitaria en todas las etapas de la viday la promoción de la excelencia en el ámbito de la salud mental, Viatris en España celebrará ...
Viatris, formed from Mylan and Pfizer's Established Brands, has faced stock price volatility since its inception in 2020. I rated Viatris a "Buy" last October, based on management's completion of ...
Aquí puede consultar la cuenta de resultados de Viatris (VTRS), mostrando el estado financiero de la compañía, los ingresos, las actividades operativas y no operativas tales como beneficios y ...
Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...
Novartis and Viatris have become the latest pharma companies to be named in lawsuits claiming that they profited from the unlawful use of HeLa cells derived from cells taken from a cancer patient ...
The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR ...
According to figures from pharmaceutical company Viatris seen by The Independent this week, more than 60 percent of Britons using it are between 25-54 years old. The publication added that Viagra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback